Target intelligence / Profile preview

Oropharyngeal structures

Molecular classification
Other
01

Overview

The oropharyngeal structures represent the middle portion of the pharynx, serving as a vital anatomical conduit for both the respiratory and digestive systems. This region is bounded superiorly by the soft palate and inferiorly by the hyoid bone, encompassing the base of the tongue, the palatine tonsils, the soft palate, and the posterior pharyngeal wall (StatPearls, 2023). Biologically, these structures are essential for critical functions such as swallowing (deglutition), maintaining airway patency during respiration, and facilitating vocal resonance for speech (Wikipedia, 2024). In a clinical context, the oropharynx is a significant site for various pathologies, most notably oropharyngeal squamous cell carcinoma (OPSCC), which is increasingly linked to high-risk Human Papillomavirus (HPV) infection (NCI, 2024). While the structures themselves are not molecular targets, they contain specific proteins and receptors, such as p16 and PD-L1, that serve as biomarkers and therapeutic targets for pharmacological interventions like pembrolizumab and cisplatin (PubMed, 2023). Understanding the complex interplay of these tissues is essential for managing conditions ranging from sleep apnea to regional malignancies.

Other names
OropharynxMiddle pharynxThroat structuresPars oralis pharyngis
02

Mechanism of action

As an anatomical region rather than a molecular target, there is no single mechanism of action; however, drugs treating diseases in this area function via DNA alkylation, EGFR inhibition, or PD-1 immune checkpoint blockade (NCI, 2024).

03

Biological functions

DeglutitionRespirationSpeech productionImmune surveillanceOther
04

Disease associations

Oropharyngeal squamous cell carcinomaPharyngitisObstructive sleep apneaTonsillitisInfectionCancerOther
05

Safety considerations

Treatment-induced dysphagiaXerostomiaSevere mucositisAirway obstructionAspiration risk
06

Interacting drugs

Cisplatin

4 more in the full profile.

07

Biomarkers

p16 (INK4a) expressionHuman Papillomavirus (HPV) DNA/RNAPD-L1 expression

Beyond the preview

Go deeper on Oropharyngeal structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oropharyngeal structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call